This $926,400 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant will fund a 3-year research project to conduct an "Integrated Immunophenotypic Transcriptomic and Epigenomic Characterization of Uterine Mesenchymal Neoplasms with Expert Pathologist Panel Review". The objectives are to advance scientific understanding and develop new treatments for these rare gynecological cancers that disproportionately impact military service members and veterans. The research will leverage Stanford's expertise in biomedical sciences, including advanced techniques in genomics, epigenomics, and immunology. This award builds on the university's extensive portfolio of federal research grants and contracts, including a $500 million Indefinite Delivery Contract with the National Heart, Lung, and Blood Institute to support precision medicine initiatives.
Generated 8/13/24, 5:50 AM